Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03667352
Other study ID # DNBT-61/2017
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date July 15, 2017
Est. completion date May 15, 2018

Study information

Verified date September 2018
Source National Institute of Mental Health and Neuro Sciences, India
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study assesses efficacy of scalp block and Ultrasound guided transverse abdominis plane (TAP) block with 1µg/kg clonidine as adjuvant to 0.2% ropivacaine versus intravenous fentanyl (0.1µg/kg/hr) on intraoperative hemodynamics and perioperative analgesia in abdominal bone flap cranioplasties (ABFC).


Description:

Scalp blocks with local anaesthetic agents along with general anaesthesia provides intraoperative and postoperative analgesia by blunting the hemodynamic responses to noxious stimuli. The transversus abdominis plane "TAP" block, a regional anaesthesia technique that provides analgesia following abdominal surgery. It involves a single large bolus injection of local anaesthetic into an anatomical space between the internal oblique and transversus abdominis muscles.

Ropivacaine is less cardio toxic, less arrhythmogenic, less toxic to central nervous system (CNS) than bupivacaine, and it also has intrinsic vasoconstrictor property. Clonidine is an alpha-2 receptor agonist, which has a known property of reducing requirement of analgesics in the perioperative period.

This study aimed to assess the efficacy of scalp block and TAP block with 1µg/kg clonidine as adjuvant to 0.2% ropivacaine versus intravenous fentanyl (0.1µg/kg/hr) on intraoperative hemodynamics and perioperative analgesia in abdominal bone flap cranioplasties.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 15, 2018
Est. primary completion date May 15, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

Patients undergoing Abdominal bone flap replacement.

Exclusion Criteria:

1. Motor and comprehensive aphasia,

2. Disoriented mental state or Inability to follow commands.

3. Hypersensitivity to amide local anesthetics,

4. Bone flap site infection

5. Coagulation disorders

Study Design


Related Conditions & MeSH terms

  • Condition: Abdominal Bone Flap Cranioplasty; Focus of Study: Perioperative Analgesia

Intervention

Procedure:
Unilateral Scalp Block
Scalp block is provided by injecting local anaesthetic in the scalp at specific areas to block 6 nerves which are responsible for sensory innervation of the scalp - Supraorbital and supratrochlear nerves, Zygomaticotemporal nerve, Auriculotemporal nerve, Greater and lesser occipital nerves.
Transversus abdominis plane block
The transverse abdominis plane (TAP) block is a peripheral nerve block designed to anesthetize the nerves supplying the anterior abdominal wall (T6 to L1). It is usually accomplished by a single bolus injection into the transversus abdominis plane through the lumbar triangle of Petit and can be accomplished either by blind landmark based technique or alternatively under ultrasound guidance (as in this study).
Drug:
Intravenous Fentanyl
Fentanyl is a commonly used opioid drug administered for analgesia in the perioperative period. It may be used as either intermittent bolus administration or continuous infusion or a combination of the two. Usual infusion doses range from 1-2 microgram/kg/hr, which may be titrated based on intraoperative haemodynamics or postoperative patient reported pain scores.

Locations

Country Name City State
India Yashoda Hospitals Secunderabad Telangana

Sponsors (1)

Lead Sponsor Collaborator
Dhritiman Chakrabarti

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in Postoperative Rescue Analgesia requirement between groups Postoperative rescue analgesia (Inj. paracetamol 1gm I.V) if patient reported pain measured by visual analogue score was = 4.
Visual analogue scale (VAS) is a self reported score for estimation of pain which ranges between 1 (no pain) to 10 (worst possible pain).
VAS score interpretation: No pain - 1, Mild pain <4, Moderate pain 4-7, Severe pain >7, Worst possible pain =10.
Measured at 1, 6 and 24 hours postoperatively.
Secondary Difference in intraoperative trend of Heart rate between groups Heart rate measured intraoperatively will be compared between the groups. Measured at 10, 20, 30, 40, 50, 60, 90, 120, 150, 180 minutes after anaesthesia induction.
Secondary Difference in intraoperative trend of Systolic blood pressure between groups Systolic blood pressure measured intraoperatively will be compared between the groups. Measured at 10, 20, 30, 40, 50, 60, 90, 120, 150, 180 minutes after anaesthesia induction.
Secondary Difference in intraoperative trend of Diastolic blood pressure between groups Diastolic blood pressure measured intraoperatively will be compared between the groups. Measured at 10, 20, 30, 40, 50, 60, 90, 120, 150, 180 minutes after anaesthesia induction.
Secondary Difference in patient reported postoperative pain Postoperative pain measured by measured by visual analogue scoring system (VAS).
Range: 1-10. No pain - 1, Mild pain <4, Moderate pain 4-7, Severe pain >7, Worst possible pain =10.
Measured at 1, 6 and 24 hours postoperatively.